Rare Pediatric Disease Designation Granted to Infantile Batten Disease Gene Therapy – Rare Disease Report
|
Rare Pediatric Disease Designation Granted to Infantile Batten Disease Gene Therapy
Rare Disease Report This morning, Abeona Therapeutics announced that the U.S. Food and Drug Administration (FDA) has granted rare pediatric disease designation to ABO-202, a gene therapy in development for the treatment of infantile and late infantile-onset Batten disease … |
